Lymphoma, T-Cell, Cutaneous
Showing 9976 - 10000 of >10,000
Esophageal Squamous Cell Carcinoma Trial in Suzhou (Sintilimab + chemo)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Sintilimab + chemotherapy
-
Suzhou, Jiangsu, ChinaThe first affiliated hospital of soochow university
Dec 13, 2021
NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose
Recruiting
- Non-small Cell Lung Cancer
- Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
- Low dose cyclophosphamide
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jan 17, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
-
Tucson, Arizona
- +9 more
Feb 10, 2022
Warts, Warts Hand, Verruca Trial in United States (CellFX Device)
Completed
- Warts
- +2 more
- CellFX Device
-
Scottsdale, Arizona
- +4 more
Sep 12, 2020
Recurrent Pregnancy Loss Trial in Maastricht, Nijmegen (Exercise)
Recruiting
- Recurrent Pregnancy Loss
- Exercise
-
Maastricht, Netherlands
- +1 more
Aug 22, 2023
Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinomas
-
Beijing, Beijing, ChinaBeijing Cancer Hostital
Mar 14, 2022
Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)
Not yet recruiting
- Renal Cancer
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jul 24, 2023
Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)
Terminated
- Carcinoma, Renal Cell
- Fitbit Versa
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Feb 21, 2022
Survivors of Transplant, CREST Study
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bioelectric Impedance Analysis
- +7 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Mar 7, 2022
Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)
Recruiting
- Olanzapine
- +3 more
- Olanzapine Tablets
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Feb 14, 2022
Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)
Not yet recruiting
- Spinal Cord Injuries
- Mesenchymal stem cell transplantation
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jan 10, 2023
Diffuse Cutaneous Systemic Sclerosis Trial in Canada, United Kingdom, United States (Abatacept, Placebo)
Completed
- Diffuse Cutaneous Systemic Sclerosis
- Abatacept
- Placebo
-
Los Angeles, California
- +26 more
Feb 13, 2020
Patients With Restenosis of Calcified Lesions
Recruiting
- Coronary Artery Calcification
- +3 more
- Coronary artery calcification lesions
-
Shenyang, Liaoning, ChinaShenyangNH
Jul 14, 2022
Pathophysiology of Anemia in PICU Survivors
Recruiting
- Anemia
-
Montréal, Quebec, CanadaHopital Ste-Justine
Jan 12, 2023
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)
Not yet recruiting
- Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
- Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 13, 2022
Observational Study About Patients Diagnosed With NAFLD
Recruiting
- Nonalcoholic Fatty Liver Disease
-
Changsha, Hunan, ChinaDepartment of Infectious Disease, Xiangya Hospital, Central Sout
Nov 25, 2022
Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,
Recruiting
- Non Small Cell Lung Cancer
- +3 more
-
Augusta, GeorgiaAugusta University Georgia Cancer Center
Mar 6, 2022
COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Benralizumab
- +2 more
- (no location specified)
Apr 26, 2022
Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Penile Cancer
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 16, 2022
Acute Lymphoblastic Leukemia Trial in United States (ADCT-402)
Terminated
- Acute Lymphoblastic Leukemia
-
La Jolla, California
- +9 more
Apr 27, 2021
Poliomyelitis Trial in Gao'an, Pingxiang (sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR
Recruiting
- Poliomyelitis
- sIPV vaccine /DTaP vaccine
- sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine
-
Gao'an, Jiangxi, China
- +1 more
Jun 20, 2022